114 results match your criteria: "Centre de Reference des Maladies Rares "Maladies Neuromusculaires"[Affiliation]"

The biofilm lifestyle of bacterial pathogens is a hallmark of chronic lung infections such as in cystic fibrosis (CF) patients. Bacterial adaptation to the complex conditions in CF-affected lungs and repeated antibiotherapies lead to increasingly tolerant and hard-to-treat biofilms. In the context of growing antimicrobial resistance and restricted therapeutic options, antimicrobial photodynamic therapy (aPDT) shows great promise as an alternative to conventional antimicrobial modalities.

View Article and Find Full Text PDF

Genetic characterization of non-5q proximal spinal muscular atrophy in a French cohort: the place of whole exome sequencing.

Eur J Hum Genet

January 2024

Hôpital Neurologique Pierre Wertheimer, Service d'électroneuromyographie et de Pathologies Neuromusculaires, Hospices Civils de Lyon, Groupement Est, Bron, France.

Proximal spinal muscular atrophy (SMA) is defined by a degeneration of the anterior horn cells resulting in muscle weakness predominantly in the proximal lower limbs. While most patients carry a biallelic deletion in the SMN1 gene (localized in chromosome 5q), little is known regarding patients without SMN1-mutation, and a genetic diagnosis is not always possible. Here, we report a cohort of 24 French patients with non-5q proximal SMA from five neuromuscular centers who all, except two, had next-generation sequencing (NGS) gene panel, followed by whole exome sequencing (WES) if gene panel showed a negative result.

View Article and Find Full Text PDF

Background: X-Linked Charcot-Marie-Tooth disease type 1 (CMTX1) is characterized by gender differences in clinical severity. Women are usually clinically affected later and less severely than men. However, their clinical presentation appears to be heterogenous.

View Article and Find Full Text PDF

Duchenne Muscular Dystrophy and Cystic Fibrosis are two major monogenetic diseases which could be treated by non-viral gene therapy. For this purpose, plasmid DNA (pDNA) coding for the functional genes requires its equipment with signal molecules favouring its intracellular trafficking and delivery in the nucleus of the target cells. Here, two novel constructions of large pDNAs encoding the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and full-length dystrophin (DYS) genes are reported.

View Article and Find Full Text PDF

Current clinical management of CIDP with immunoglobulins in France: An expert opinion.

Rev Neurol (Paris)

October 2023

Service de neurologie, centre de référence des maladies neuromusculaires et SLA, hôpital de la Timone, Marseille, France. Electronic address:

Treatment strategies in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) must be adapted on a case-to-case basis. Validated and reproducible tools for monitoring treatment response are required at diagnosis, when initiating treatment and throughout follow-up. A task force of French neurologists, experts in neuromuscular disease reference centers, was assembled to provide expert advice on the management of typical CIDP with intravenous immunoglobulins (Ig), and to harmonize treatment practices in public and private hospitals.

View Article and Find Full Text PDF

Gene transfection using branched cationic amphiphilic compounds for an aerosol administration in cystic fibrosis context.

Int J Pharm

January 2023

Univ Brest, INSERM, EFS, UMR 1078, GGB, F-29200 Brest, France; CHRU de Brest, Service de Génétique Médicale et de Biologie de la Reproduction, Centre de Référence des Maladies Rares Maladies Neuromusculaires, 29200 Brest, France. Electronic address:

For cystic fibrosis gene therapy, the aerosolization of genetic materials is the most relevant delivery strategy to reach the airway epithelium. However, aerosolized formulations have to resist shear forces while maintaining the integrity of plasmid DNA (pDNA) during its journey from the nebulization to the epithelial cells. Herein, we compared the efficiency of gene delivery by aerosolization of two types of formulations: (i) BSV163, a branched cationic amphiphilic compound, co-formulated with different DOPE ratios (mol/mol) and DMPE-PEG5000 and (ii) 25 KDa branched polyethylenimine (b-PEI)-based formulation used as control.

View Article and Find Full Text PDF

Purpose: In this study, we describe the phenotype and genotype of the largest cohort of patients with Joubert syndrome (JS) carrying pathogenic variants on one of the most frequent causative genes, .

Methods: We selected 53 patients with pathogenic variants on , compiled and analysed their clinical, neuroimaging and genetic information and compared it to previous literature.

Results: Developmental delay (motor and language) was nearly constant but patients had normal intellectual efficiency in 74% of cases (20/27 patients) and 68% followed mainstream schooling despite learning difficulties.

View Article and Find Full Text PDF

Synthesis of Double Hydrophilic Block Copolymers Poly(2-isopropyl-2-oxazoline-b-ethylenimine) and their DNA Transfection Efficiency.

Macromol Biosci

January 2023

Institut Parisien de Chimie Moléculaire, Equipe Chimie des Polymères, UMR 8232 CNRS, Sorbonne University, Paris, Cedex 05, 75252, France.

Gene delivery is now a part of the therapeutic arsenal for vaccination and treatments of inherited or acquired diseases. Polymers represent an opportunity to develop new synthetic vectors for gene transfer, with a prerequisite of improved delivery and reduced toxicity compared to existing polymers. Here, the synthesis in a two-step's procedure of linear poly(ethylenimine-b-2-isopropyl-2-oxazoline) block copolymers with the linear polyethylenimine (lPEI) block of various molar masses is reported; the molar mass of the poly(2-isopropyl-2-oxazoline) (PiPrOx) block has been set to 7 kg mol .

View Article and Find Full Text PDF

Sjögren syndrome and RFC1-CANVAS sensory ganglionopathy: co-occurrence or misdiagnosis?

J Neurol

January 2023

Centre de Référence des Maladies Neuromusculaires Nord/EstIle-de-France, Groupe Hospitalier Pitié-Salpêtrière Charles-Foix, APHP, 47-83 bd de l'Hôpital, 75013, Paris, France.

Background And Aims: RFC1-CANVAS and primary Sjögren syndrome (pSS) are among the most frequent causes of sensory ganglionopathy (SG) and can present simultaneously in a given patient, sharing confounding signs and symptoms. We describe the clinical characteristics of patients with SG due to CANVAS who were suspected of having or had received a previous diagnosis of pSS.

Methods: Patients with SG and a genetically confirmed RFC1-CANVAS followed in our centre were ascertained and their personal history of pSS was collected.

View Article and Find Full Text PDF

Antimicrobial photodynamic therapy (aPDT) depends on a variety of parameters notably related to the photosensitizers used, the pathogens to target and the environment to operate. In a previous study using a series of Ruthenium(II) polypyridyl ([Ru(II)]) complexes, we reported the importance of the chemical structure on both their photo-physical/physico-chemical properties and their efficacy for aPDT. By employing standard in vitro conditions, effective [Ru(II)]-mediated aPDT was demonstrated against planktonic cultures of and strains notably isolated from the airways of Cystic Fibrosis (CF) patients.

View Article and Find Full Text PDF

Effects of the Sex Steroid Hormone Estradiol on Biofilm Growth of Cystic Fibrosis Isolates.

Front Cell Infect Microbiol

August 2022

Physical Chemistry I and Research Center of Micro- and Nanochemistry and (Bio)Technology (Cμ), Department of Chemistry and Biology, University of Siegen, Siegen, Germany.

Women with cystic fibrosis (CF) have a significantly lower life expectancy compared to men, which is indicated by an earlier impairment of lung function due to chronic colonization with biofilm formed by . There is growing evidence that blood serum concentrations of the steroid sex hormone estradiol (E) correlate with the occurrence of pulmonary exacerbations in CF but also play a role in the mucoid switch of . This study aims to shed light on possible microbiological reasons for sexual dimorphism in CF by investigating the influence of E on biofilm formation of .

View Article and Find Full Text PDF

In nonviral gene therapy approaches, the linkage of signal molecules to plasmid DNA (pDNA) is of interest for guiding its delivery to the nucleus. Here, we report its linkage to a peptide (P) mediating migration on microtubules by using a triplex-forming oligonucleotide (TFO). pDNA of 5 kbp and 21 kbp containing 6 and 36 oligopurine • oligopyrimidine sites (TH), respectively, inserted outside the luciferase gene sequence were used.

View Article and Find Full Text PDF

Diaphragmatic weakness related to radiotherapy: 2 cases and a review.

Rev Neurol (Paris)

October 2022

Centre de référence des Maladies Neuromusculaires, CHU Lille, 59000 Lille, France; Service de Neurologie et pathologie du mouvement, CHU Lille, 59000 Lille, France.

Post-radiation diaphragmatic weakness have rarely been described. We report two cases of post-radiation diaphragmatic weakness from our center, and review the other published cases, computing clinical, electromyography and magnetic resonance imaging data. Including our two cases, seven cases of post-radiation diaphragmatic weakness have been described.

View Article and Find Full Text PDF

Unravelling the impact of frontal lobe impairment for social dysfunction in myotonic dystrophy type 1.

Brain Commun

May 2022

Institut du Cerveau et de la Moelle épinière (ICM), UMRS 975, ICM-INSERM 1127, 75013 Paris, France.

Myotonic dystrophy type 1 is an autosomal dominant multisystemic disorder affecting muscular and extra muscular systems, including the central nervous system. Cerebral involvement in myotonic dystrophy type 1 is associated with subtle cognitive and behavioural disorders, of major impact on socio-professional adaptation. The social dysfunction and its potential relation to frontal lobe neuropsychology remain under-evaluated in this pathology.

View Article and Find Full Text PDF

Long-Reads Sequencing Strategy to Localize Variants in TTN Repeated Domains.

J Mol Diagn

July 2022

Molecular Diagnostic Laboratory, Montpellier University Hospital, Montpellier, France; PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France. Electronic address:

Article Synopsis
  • Titin protein, encoded by the TTN gene with 364 exons, is key for muscle elasticity and has various isoforms due to extensive alternative splicing in skeletal and cardiac muscles.
  • Variants in the TTN gene can cause myopathies with diverse symptoms and can be transmitted in dominant or recessive patterns.
  • The implementation of long-reads sequencing technology helps accurately identify and locate variants in complex repeated regions of the TTN gene, enhancing diagnosis and screening for TTN-related myopathies in patients and their relatives.
View Article and Find Full Text PDF

Small fiber neuropathies affect small, poorly myelinated sensory Aδ and amyelinated C autonomic fibers. Neuropathic pain is often the main symptom. Positive diagnosis is based on the presence of deficient thermo-algesic sensory signs and/or dysautonomic signs with normal neurography.

View Article and Find Full Text PDF

Nitrous oxide abuse in the emergency practice, and Review of toxicity mechanisms and potential markers.

Food Chem Toxicol

April 2022

Inserm, Univ. Lille EA 7364 RADEME, CHU Lille, Centre de Biologie Pathologie Génétique, UF Métabolisme Général et Maladies Rares, F-59000, Lille, France. Electronic address:

Nitrous oxide (NO) toxicity is a concern common to several medical fields. Here, retrospective study of four NO abuses with neurological signs in the emergency practice provides a preliminary basis for a metabolic Discussion/Review. This latter highlights NO abuse as pathology of DNA/RNA/protein methylations, for instance consistent with impairments of protein arginine methyltransferases involved in myelinogenesis and myelopathy in patients.

View Article and Find Full Text PDF

The objective was to investigate whether resveratrol (RSV) can improve exercise capacity in patients with fatty acid oxidation (FAO) disorders. The study was a randomized, double-blind, cross-over trial. Nine patients with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency or carnitine palmitoyl transferase (CPT) II deficiency were randomized to receive either 8 weeks of 1000 mg day RSV or placebo (P) followed by a 4-weeks wash-out period and subsequently 8 weeks of the opposite treatment.

View Article and Find Full Text PDF

Aerosol lung gene therapy using non-viral delivery systems represents a credible therapeutic strategy for chronic respiratory diseases, such as cystic fibrosis (CF). Progress in CF clinical setting using the lipidic formulation GL67A has demonstrated the relevance of such a strategy while emphasizing the need for more potent gene transfer agents. In recent years, many novel non-viral gene delivery vehicles were proposed as potential alternatives to GL67 cationic lipid.

View Article and Find Full Text PDF

Antimicrobial photodynamic therapy (aPDT) has become a fundamental tool in modern therapeutics, notably due to the expanding versatility of photosensitizers (PSs) and the numerous possibilities to combine aPDT with other antimicrobial treatments to combat localized infections. After revisiting the basic principles of aPDT, this review first highlights the current state of the art of curative or preventive aPDT applications with relevant clinical trials. In addition, the most recent developments in photochemistry and photophysics as well as advanced carrier systems in the context of aPDT are provided, with a focus on the latest generations of efficient and versatile PSs and the progress towards hybrid-multicomponent systems.

View Article and Find Full Text PDF

A convergent synthesis of cationic amphiphilic compounds is reported here with the use of the phosphonodithioester-amine coupling (PAC) reaction. This versatile reaction occurs at room temperature without any catalyst, allowing binding of the lipid moiety to a polar head group. This strategy is illustrated with the use of two lipid units featuring either two oleyl chains or two-branched saturated lipid chains.

View Article and Find Full Text PDF

The mucus obstructing the airways of Cystic Fibrosis (CF) patients is a yield stress fluid. Linear and non-linear rheological analyses of CF sputa can provide relevant biophysical markers, which could be used for the management of this disease. Sputa were collected from CF patients either without any induction or following an aerosol treatment with the recombinant human DNAse (rhDNAse, Pulmozyme).

View Article and Find Full Text PDF

Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study.

Neurology

February 2022

From Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, and Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle (A.G.-D., R.M.), Service d'Imagerie Médicale (R.A.), and Centre de Référence des Syndromes Neurologiques Paranéoplasiques et Encéphalites Auto-immunes (V.R., B.J., S.M.-C., A.V., G.P., J.H.), Hôpital Neurologique Pierre Wertheimer, and Service de Neurologie Pédiatrique, Hôpital Femme Mère Enfant (C.F.), Hospices Civils de Lyon, Lyon/Bron; Institut NeuroMyoGène (V.R., B.J., S.M.-C., A.V., G.P., J.H.), INSERM 1217 et CNRS UMR5310; Université Claude Bernard Lyon 1 (V.R., B.J., S.M.-C., A.V., G.P., J.H.), Faculté de Médecine Lyon Est; Centre de Recherche en Neurosciences de Lyon (A.R., R.M.), INSERM 1028 et CNRS UMR5292, France; Stanford University Center for Sleep Sciences and Medicine (A.A.), Palo Alto, CA; Service de Neurologie Cognitive, Épilepsie, Sommeil et Mouvements Anormaux (M. Benaiteau) and Service de Neurologie Inflammatoire et Neuro-oncologie (F.R., J.C.), Hôpital Pierre-Paul Riquet, Hôpitaux de Toulouse; Service de Neuropédiatrie (K.D.), Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre; Service de Neurologie (T.d.B.), Hôpital Delafontaine, Centre Hospitalier de Saint-Denis; Service de Neurologie, Hôpital de Hautepierre (L.K.), Hôpitaux Universitaires de Strasbourg; Service de Neurologie (P.K.), Centre Hospitalier de Luxembourg; Service de Neurologie (F.S.) and Service de Médecine Interne (B.B.), Hôpitaux Civils de Colmar; Unité INSERM U-1118 (F.S.), Faculté de Médecine, Université de Strasbourg; Service de Médecine Interne (R.G.), Hôpital d'Instruction des Armées Legouest, Metz; Service de Neurologie (J.B.) and Service de Médecine Interne et Immunologie Clinique (A.B.), Centre Hospitalier Régional Universitaire de Tours; Service de Neurologie et Maladies Neuromusculaires (F.D.), Groupe Hospitalier Pellegrin, Hôpitaux de Bordeaux; Service de Médecine Intensive et Réanimation (N.I.), Hôpital Saint André, Bordeaux; Service de Neurologie (E.-C.R.), Hôpital Sainte Musse, Centre Hospitalier Intercommunal de Toulon; Service de Neurologie (M.G.), Hôpital Emile Muller, Mulhouse; Service de Neurologie (A.D.), Centre Hospitalier de Perpignan; Pôle Cardio-vasculaire et Métabolique (J.L.D.), Centre Hospitalier de Cayenne; Service de Neurologie (L.H.), Hôpital Central, CHRU Nancy; Service de Neurologie (A.-L.K.), CHU de Saint-Etienne, Saint-Priest-en-Jarez; Service de Neuropédiatrie (M.P.), Site Mère Enfant, CHU Martinique, Fort-de-France; Service de Neurologie (E.C.), CHU Gabriel-Montpied, CHU de Clermont-Ferrand; Service de Neurologie (A.L.), Hôpital d'Instruction des Armées Clermont-Tonnerre, Brest; Service de Neurologie (E.M.), Hôpital Fondation Adolphe de Rothschild, Paris; Service de Neurologie et Laboratoire de Neurosciences Fonctionnelles et Pathologies (D.A.), Centre Hospitalier Universitaire d'Amiens et Université de Picardie Jules Verne, Amiens; Service de Neurologie (P.D.), Hôpital Laënnec, Centre Hospitalier de Cornouaille, Quimper; Service de Neurologie (G.M.), Centre Hospitalier Universitaire de La Réunion, Saint Pierre; Service de Neurologie (C.D.), Hôpital Roger Salengro, Centre Hospitalier Universitaire de Lille; Service de Neurologie (V.B.), Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice; Service de Médecine Interne et Maladies Infectieuses (Q.B.), Centre Hospitalier d'Angoulême; Service de Neurologie (I.G.-C.) and Service de Réanimation (G.R.), Centre Hospitalier de Saint-Brieuc; Service de Médecine Polyvalente et de Médecine Interne (D.M.-T.), Centre Hospitalier Le Mans; Service de Neurologie (M. Bonnan), Centre Hospitalier de Pau; and Service de Neurologie/UNV (T.T.), Centre Hospitalier de Saintonge, Saintes, France.

Background And Objectives: To report the clinical, biological, and imaging features and clinical course of a French cohort of patients with glial fibrillary acidic protein (GFAP) autoantibodies.

Methods: We retrospectively included all patients who tested positive for GFAP antibodies in the CSF by immunohistochemistry and confirmed by cell-based assay using cells expressing human GFAPα since 2017 from 2 French referral centers.

Results: We identified 46 patients with GFAP antibodies.

View Article and Find Full Text PDF

A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course.

Acta Neuropathol Commun

September 2021

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Inserm U 1258, CNRS UMR 7104, Université de Strasbourg, Illkirch, France.

The ryanodine receptor RyR1 is the main sarcoplasmic reticulum Ca channel in skeletal muscle and acts as a connecting link between electrical stimulation and Ca-dependent muscle contraction. Abnormal RyR1 activity compromises normal muscle function and results in various human disorders including malignant hyperthermia, central core disease, and centronuclear myopathy. However, RYR1 is one of the largest genes of the human genome and accumulates numerous missense variants of uncertain significance (VUS), precluding an efficient molecular diagnosis for many patients and families.

View Article and Find Full Text PDF